Gross Profit Margin (Quarterly) Chart

Historical Gross Profit Margin (Quarterly) Data

View and export this data back to 1996. Start Trial.
Date Value
September 30, 2026 73.00%
June 30, 2026 68.73%
March 31, 2026 66.91%
December 31, 2025 66.77%
September 30, 2025 69.72%
June 30, 2025 68.49%
March 31, 2025 66.84%
December 31, 2024 67.89%
September 30, 2024 69.19%
June 30, 2024 68.99%
March 31, 2024 68.78%
December 31, 2023 67.68%
September 30, 2023 69.53%
June 30, 2023 69.73%
March 31, 2023 68.68%
December 31, 2022 70.17%
September 30, 2022 69.58%
June 30, 2022 67.15%
March 31, 2022 67.88%
December 31, 2021 67.17%
September 30, 2021 69.26%
June 30, 2021 67.59%
March 31, 2021 68.61%
December 31, 2020 65.43%
September 30, 2020 67.46%
Date Value
June 30, 2020 64.58%
March 31, 2020 66.76%
December 31, 2019 66.24%
September 30, 2019 67.35%
June 30, 2019 66.95%
March 31, 2019 67.28%
December 31, 2018 65.91%
September 30, 2018 67.25%
June 30, 2018 66.56%
March 31, 2018 66.92%
December 31, 2017 64.04%
September 30, 2017 65.07%
June 30, 2017 69.34%
March 31, 2017 69.94%
December 31, 2016 69.61%
September 30, 2016 69.17%
June 30, 2016 71.10%
March 31, 2016 69.77%
December 31, 2015 68.43%
September 30, 2015 69.70%
June 30, 2015 69.67%
March 31, 2015 69.27%
December 31, 2014 67.91%
September 30, 2014 70.57%
June 30, 2014 68.56%

Gross Profit Margin Definition

Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.

Read full definition.

Gross Profit Margin (Quarterly) Range, Past 5 Years

View Gross Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit Margin (Quarterly) Benchmarks

View Gross Profit Margin (Quarterly) Benchmarks
Start Trial
Eli Lilly & Co. 85.78%
Merck & Co., Inc. 71.51%
Pfizer Inc. 62.94%
Bristol Myers Squibb Co. 67.95%
Liquidia Corp. 93.10%

Gross Profit Margin (Quarterly) Related Metrics